Sell Your Veterinary Practice in Idaho in 2026: 5-13x by Tier, PE Platforms, CPVM Structure

Selling your veterinary practice in Idaho in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Active ID buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland, plus MedVet for doctor-controlled CPVM exits.

Veterinary practice sales in Idaho run on a different map than almost any other state, because Idaho is really three disconnected markets wearing one license. Boise and the wider Treasure Valley are a fast-growing, self-contained metro that already has a national platform on the ground; the panhandle around Coeur d’Alene answers to Spokane across the Washington line; and eastern Idaho around Idaho Falls and Pocatello sits hours from any consolidation hub. What an Idaho practice is worth, and who will even bid on it, depends first on which of those three Idaho you are in. Cumulative private-equity investment in US veterinary reached $51.6 billion across 2017 to 2023 with another $9.3 billion in the first four months of 2024 alone (American Economic Liberties Project), and private-equity buyers supplied roughly 80% of 2024 veterinary deal capital, but that national firehose reaches Idaho unevenly.

This guide is written for the Idaho DVM who wants the price and the path, not national averages that ignore geography. It walks through 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the consolidators actually operating in or reaching into Idaho, and the parts of an Idaho deal that differ from the national template: the fact that Idaho is a corporate-practice-restricted state under Idaho Code section 54-2113, so a private-equity buyer must use a friendly professional entity plus a management services organization rather than a simple stock purchase; the thin, out-of-state DVM pipeline that runs through the WIMU regional program at Washington State in Pullman; and Idaho’s flat 5.3% income tax with its 60% deduction on qualifying long-term Idaho real property, which shapes how much of the check you keep.

CT Acquisitions runs confidential, buy-side processes. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. For wider context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.

How Idaho veterinary practices are valued in 2026, the tiered framework

Idaho veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers use nationally, but read against a bidder pool that is deep in Boise and thin almost everywhere else. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the floor where corporate diligence pays off, so it usually sells between DVMs. Move up the tiers and, if you are in the Treasure Valley, the platform starts bidding.

Idaho veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against an Idaho bidder pool that is concentrated in one metro. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself and typically clears 5x to 7x, changing hands between DVMs or small regional groups rather than going to a platform. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on one doctor. The four-to-eight-DVM hospital at $1M to $3M is the tier a platform competes hardest for and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital an aggregator wants for geographic fill. Specialty, emergency and 24/7 hospitals carry a 1.5x to 3x premium over general practice. R.L. Hulett Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline. The Idaho wrinkle is that these tiers only convert to real competition where a buyer can reach you: in Boise the tiers behave like the national market, while in eastern Idaho the same tier may draw a single take-it-or-leave-it bid.

Idaho practice profile	Typical multiple	What moves it in Idaho
Single-DVM lifestyle / rural mixed-animal under $500K EBITDA	5-7x EBITDA	Below the platform diligence floor; sells DVM-to-DVM, common across the Magic Valley and the eastern counties
2-3 DVM general practice ($500K-$1M EBITDA)	7-9.5x EBITDA	Draws real interest in the Treasure Valley, where Thrive is already clustered; thin elsewhere
4-8 DVM hospital ($1M-$3M EBITDA)	9.5-11.5x EBITDA (clean books to 12x)	The tier a Boise platform competes for; associate bench and wellness penetration decide the top end
$3M+ EBITDA multi-doctor / specialty / referral	11-13x EBITDA (16-18x for marquee specialty)	The All Valley 24/7 ER and specialty cluster anchors Treasure Valley referral demand
Multi-site groups (3+ hospitals)	12-15x EBITDA	Rare in Idaho; a Treasure Valley mini-group would command platform-of-platform pricing

The lever that separates a floor multiple from a competitive one is whether a buyer can actually reach you. A four-doctor Boise hospital with $1.5M of EBITDA taken quietly to one strategic buyer might settle at 9.5x to 10.5x, roughly $14M to $16M. Run as a competitive process that pulls Thrive against a national platform willing to plant a second flag in a fast-growing metro, that same hospital can pull one to two turns more. The same practice sitting in Idaho Falls, three hours from Boise and Salt Lake, has no such tension and tends to clear the floor of its tier unless its scale and real estate justify the distance.

The wellness-plan / membership premium, the single biggest GP valuation lever

For an Idaho general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and it matters even more in Idaho because the fast-growing, affluent Boise client base is exactly the demographic that sustains a plan.

For an Idaho general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients across the US, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans. In Idaho the premium is especially real in the Treasure Valley, where Boise ranks among the fastest-growing and fastest-affluent metros in the country, so a Boise membership book is backed by a client base that is both growing and able to pay, which is precisely what a general-practice roll-up underwrites. The way to capture the premium in an Idaho process is to stand the plan up 18 to 24 months before you go to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Idaho hospitals that arrive at market with more than 20% penetration and average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional practice in a rural county with thin repeat visits and a shallow client base gets marked down in the same diligence.

Earnouts, DVM retention, and what Idaho platform buyers underwrite

In Idaho deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, and in Idaho that constraint is sharper because the DVM labor pipeline is thin and out of state. The structure leans hard on the seller and the associate bench staying put.

In Idaho deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention rather than patient demand, and Idaho makes that worry sharper because there is no in-state vet school and the regional pipeline is capped and partly leaky. A typical Idaho two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or a platform-level holding company and 5 to 15% held as an earnout keyed to the selling doctor clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. The recurring fight is production-comp normalization: many Idaho owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. The clawbacks have teeth: a typical structure fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window in the earnout period, and an associate departure inside 18 months releases part of the escrow back to the buyer. Because Idaho sits in a corporate-practice-restricted framework, the earnout and rollover are documented at the management-company level and against the selling vet professional entity rather than a single operating company, which counsel builds into the structure from the start.

Platform-versus-tuck-in arbitrage, the 5-7 turn multiple expansion

The gap between what a platform pays for a single Idaho hospital and what that hospital is worth once it sits inside a larger group is why Thrive bothered to plant a flag in Boise at all. That spread is where the premium a Treasure Valley seller can capture actually lives, and it is far harder to reach from an isolated eastern-Idaho market.

The gap between what a platform pays for a single Idaho hospital and what that hospital is worth once it sits inside a larger group is the reason a national consolidator will pay up for the right Boise practice. A standalone four-doctor general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer books, which is why a buyer that wants to build out the Treasure Valley will pay 11x to 12x for a $1M to $2M hospital it wants. The catch for an Idaho seller is that the premium only shows up when the buyer actually wants your geography. In Boise, where Thrive already runs the All Valley cluster and the metro is growing fast, the geography is genuinely on-thesis and the arbitrage is reachable. In the panhandle the relevant buyer pool is Spokane, not Boise, and in eastern Idaho there may be no platform for whom the location clears the drive-time math, so an off-thesis hospital gets the floor multiple regardless of how much national capital exists. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021 to 2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why buyers are looking harder at fast-growing western metros like Boise again in 2026.

Who is buying Idaho veterinary practices in 2024-2026, named platforms with CURRENT ownership

The Idaho buyer pool is the national buyer pool, but only one of its members has so far planted a confirmed clinic inside the state: Thrive Pet Healthcare, which runs the All Valley 24/7 emergency and specialty cluster in Meridian. The rest reach Idaho from out of state or not at all, so an Idaho seller is really tracking which national platform is willing to enter a growing but still early market.

The Idaho buyer pool is the national buyer pool, and the group that matters most here is the one with a confirmed Idaho footprint: Thrive Pet Healthcare, backed by TSG Consumer Partners, which operates the All Valley Animal Care Center in Meridian in the Boise metro, a 24/7 emergency hospital with specialty and surgical services that functions as the Treasure Valley referral and ER backstop. That gives Boise a live platform buyer and a proof point that the corporate-practice structure works in Idaho. Beyond Thrive, the national platforms are the same ones acquiring everywhere and will enter Idaho when a target clears their size and geography bars. Mars Veterinary Health is the largest, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, backed by Shore Capital Partners, reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners. VetCor is led by Oak Hill Capital with Harvest Partners and Cressey & Co. and has been among the most active general-practice tuck-in buyers. PetVet Care Centers has been owned by KKR since 2022, not Onex. Heartland Veterinary Partners is now Gryphon Investors majority after its 2024 to 2025 recap, not American Securities, and AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap, not Imperial Capital. Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus urgent care) and VetEvolve (Varsity Healthcare). The doctor-controlled route is real in Idaho too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan, both genuine options for an Idaho owner who wants liquidity without handing clinical control to a fund.

Veterinary sub-verticals and how each is valued

Buyers rank Idaho veterinary sub-verticals on the same hierarchy they use nationally, but Idaho species mix tilts it: general practice is the backbone of the platform thesis, specialty and emergency sit at the top of the range and are concentrated in Boise, and the state large base of mixed-animal and food-animal work is a separate, thinner buyer pool.

Buyers rank Idaho veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital with strong referral catchment, but in Idaho that work is concentrated almost entirely in the Treasure Valley, where the All Valley cluster already anchors referral and overnight cases. Emergency, urgent-care and 24/7 hospitals carry 11x to 13x on the scarcity of overnight staffing and the specialty cross-sell, and Idaho has very few of them outside Boise, which makes the ones that exist scarce and valuable. Mixed-animal, equine and food-animal practices are a larger share of the map in Idaho than in most states, given the state ranching, dairy and cattle base across the Magic Valley and the eastern counties, and they are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. Multi-site groups of three or more hospitals are the single most attractive archetype, but they are rare in Idaho outside the Treasure Valley, where a buyer would pay platform-of-platform multiples of 12x to 15x for proven multi-site capability.

Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.

Idaho veterinary market context

Idaho is a corporate-practice-restricted state, so a platform cannot simply buy your practice; it must use a friendly professional entity plus a management company. Demand is sharply concentrated in the fast-growing Boise metro, while the DVM labor pipeline is small and sits across the state line in Washington.

Idaho restricts ownership of a veterinary practice, which is the first thing that separates it from permissive states. Idaho Code section 54-2113 allows a practice to be conducted only as a sole proprietorship, a partnership, or a professional entity, and bars an ordinary business corporation from providing veterinary services, so a corporate or private-equity buyer operates through a management services organization paired with a vet-owned professional entity rather than a direct purchase. Demand is concentrated where the people and the money are, and in Idaho that means the Treasure Valley. Boise is one of the fastest-growing metros in the country, up more than 10% since 2020 with a large share of in-migration from California per the Boise Valley Economic Partnership, and Idaho led the nation in median-income growth at roughly 15.5%, which is exactly the durable, affluent demand that general-practice roll-ups pay a premium for. The constraint is labor. Idaho has no veterinary college of its own, and its DVM pipeline runs through the WIMU regional program at Washington State in Pullman, which admits roughly 11 Idaho residents a year, an out-of-state and partly-leaky pipeline that sits nowhere near Boise. Buyers weigh that staffing risk heavily, softened in the Treasure Valley by strong professional in-migration and unoffset in rural and eastern Idaho. The result is a bifurcated map: Boise is a genuine emerging-platform market, the panhandle belongs to Spokane buyer orbit, and eastern Idaho and the rural counties stay the thinnest part of the state.

Which buyers are actually near your Idaho practice, and what your location does to your negotiating position

Boise is a self-contained growth market with at least one platform already on the ground. The rest of Idaho is decided by which out-of-state metro you can drive to, not by the state line.

• Thrive Pet Healthcare: GP + emergency/urgent + specialty consolidator (~476 locations nationally per buyer universe)

Idaho is not one market, it is three that don’t touch. Boise is a fast-growing, self-contained metro with a platform (Thrive/All Valley) already in it, the state’s one genuine institutional-interest story, but a self-contained one because no out-of-state hub is within 2 hours. The panhandle (Coeur d’Alene) belongs to Spokane’s orbit, 36 minutes away. Eastern Idaho (Idaho Falls/Pocatello) is stranded ~3 hours from both Boise and Salt Lake. Same state license, three completely different buyer conversations.

Your location scored on five factors

Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Idaho reads on all five.

Factor	What it means for your exit
Buyers near you	One confirmed in-state platform, Thrive Pet Healthcare (All Valley), already runs a Boise-Meridian GP-plus-24/7-ER cluster, so proximity is real in the Treasure Valley; the panhandle’s real proximity is to Spokane (~36 min), and eastern/rural Idaho has no metro within 2 hours (Boise’s own 2-hr reach is essentially intra-Idaho, out-of-state metros are 4.5-7 hr away).
Your size gate	Sliding scale: in Boise a platform is already on the ground so even a solid single-to-multi-DVM practice can be a tuck-in (bar LOW and falling with growth); in isolated eastern/rural Idaho a practice must carry multi-DVM scale, strong EBITDA, and ideally owned real estate to justify a standalone buyer, or it sells local.
Metro depth	Boise MSA (~846K) is large for Idaho and compact enough for cluster economics, but there is no OTHER in-state metro within 2 hours and no out-of-state bench to borrow, so bidder depth is real only in Boise and still early (one confirmed platform); Coeur d’Alene (~188K) and Idaho Falls (~171K) are small and point out-of-state or nowhere.
DVM labor supply	No Idaho vet school; the pipeline is the WIMU regional program at Washington State (Pullman), a capped (~11 Idaho seats/yr) out-of-state, partly-leaky pipeline nowhere near Boise, so staffing risk is a valuation variable, partly offset in Boise by strong professional in-migration, unoffset in rural/eastern Idaho.
Demand trend	Boise is one of the fastest-growing, fastest-affluent metros in the U.S. (~10%+ since 2020, ~46% of in-migration from California per BVEP; Idaho led the nation in median-income growth ~15.5%), a genuine and durable demand tailwind concentrated in the Treasure Valley; rural/ag and eastern Idaho underwrite as stable-to-flat.

If you are in Boise or the wider Treasure Valley, a national platform (Thrive Pet Healthcare, through its All Valley group) is already operating a Boise-Meridian cluster with a 24/7 emergency backstop, so there is a live institutional buyer on the ground and a real path for others to follow. But proximity only converts if you clear the size bar, and in Boise that bar is genuinely low and getting lower: because a platform is already clustered here, a clean single-to-multi-DVM practice can be absorbed as a tuck-in rather than a first flag-plant. The rest of the state is a different conversation. The panhandle (Coeur d’Alene) is 36 minutes from Spokane and belongs to Spokane’s buyer orbit, not Boise’s. Eastern Idaho (Idaho Falls, Pocatello) is stranded roughly three hours from both Boise and Salt Lake, inside neither’s cluster, so there a practice must carry real standalone scale or it sells to a local or regional DVM. Crucially, Boise itself is self-contained: no out-of-state metro is within 2 hours (Salt Lake is ~5, Spokane ~4.5, Portland ~7), so Boise cannot borrow another state’s buyer bench the way a border town can, which is why in-market platform presence is still early rather than a crowded auction.

MSA depth reinforces this split. Boise (~846K) is large for Idaho and compact enough for cluster economics, but there is no second in-state metro within 2 hours and no bench to import, so genuine bidder tension exists mainly in the Treasure Valley and is still developing. Labor is the recurring caution: Idaho has no vet school, and its pipeline runs through the WIMU regional program at Washington State in Pullman, a capped (~11 Idaho seats a year), out-of-state, partly-leaky pipeline that sits nowhere near Boise. A buyer will ask whether the practice can be staffed after the founder slows down; in Boise, strong professional in-migration softens that worry, while in rural and eastern Idaho it is a direct valuation drag or a longer lock-in. What tips Boise from small-base curiosity to genuine emerging-platform interest is demand: Boise is one of the fastest-growing and fastest-affluent metros in the country (over 10% growth since 2020, roughly 46% of in-migration from California per the Boise Valley Economic Partnership, and Idaho led the nation in median-income growth at about 15.5%), which is precisely the durable, growing, wellness-plan demand that GP roll-ups pay a premium for.

On structure and tax, Idaho is workable but has edges. It is a corporate-practice-restricted state: Idaho Code section 54-2113 allows a practice to be owned only as a sole proprietorship, partnership, or professional entity, and bars ordinary business corporations, so a platform buys you through an MSO plus DVM-owned professional-entity structure rather than a simple stock deal (Thrive’s presence proves the model works, but it is a real step). On non-competes, Idaho briefly went employer-friendly in 2016 then repealed that in 2018, landing back on a reasonableness standard where a covenant with a KEY employee is enforceable if reasonable in duration (18 months or less is presumed reasonable) and geography; that means a buyer can still bind you as the selling owner and can still hold reasonable non-competes on key associate DVMs, a modest retention comfort relative to neighboring void-by-default states. On tax, Idaho’s flat rate dropped to 5.3% in 2025 and taxes gains as ordinary income, but the section 63-3022H deduction lets you exclude up to 60% of the gain on qualifying Idaho real property held 12+ months, which can materially cut the state tax on a practice’s real-estate component. Net: Boise is the real Idaho story, a fast-growing, self-contained, platform-anchored market where growth and Thrive’s presence do much of the work of pulling proximity across the size gate; the panhandle answers to Spokane, eastern and rural Idaho answer to no one within 2 hours, and everywhere the thin, out-of-state WIMU labor pipeline is the factor buyers underwrite most cautiously.

State CPVM framework, premise permits, and FTC scrutiny for an Idaho sale

Selling an Idaho veterinary practice touches three regulatory layers, and the first is the one that shapes the whole deal structure: Idaho restricts ownership to veterinarians and professional entities under Idaho Code section 54-2113, so a corporate buyer must build a friendly professional entity plus a management services organization. The other two layers are federal DEA registration and the antitrust backdrop.

Selling an Idaho veterinary practice touches three regulatory layers, and the first one drives the entire structure. Idaho is a corporate-practice-restricted state: under Idaho Code section 54-2113 a veterinary practice may be conducted only as a sole proprietorship, a partnership, or a professional entity, and no ordinary business corporation may provide veterinary services. The statute carries one narrow carve-out, that a not-for-profit organization may own property where veterinary services are rendered provided a licensed veterinarian makes all medical decisions, but that exception is not available to a for-profit private-equity buyer. The practical consequence is that a corporate buyer cannot hold your practice directly. Instead the buyer uses a friendly professional entity owned by an Idaho-licensed veterinarian to hold the license and employ the DVMs, paired with a separate management services organization owned by the sponsor that holds the non-clinical assets and provides administration under a management services agreement, with a share-transfer-restriction agreement keeping the professional entity friendly and the management company barred from controlling clinical judgment. Thrive presence in Meridian proves this structure works in Idaho, but it adds cost and steps a permissive-state deal avoids, often $50K to $150K in extra legal work. The second layer is federal and unchanged by state law: each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, though in a thin market like Idaho a single-practice sale rarely triggers that scrutiny.

How this applies to an Idaho veterinary practice sale

For an Idaho seller the sequence starts with structure, not with a facility license. First, ownership: because Idaho bars corporate ownership under section 54-2113, the deal is built as a friendly professional entity plus management services organization from the outset, and the time to engage counsel who structures these is before you sign a letter of intent, not during diligence. Second, licensure with the Idaho Board of Veterinary Medicine: the professional entity holds the practice and its licensed veterinarian of record, and the board is notified of the ownership and personnel changes the transaction creates. Third, DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222, with the Idaho Board of Pharmacy registration updated in parallel. Fourth, antitrust: in most Idaho deals this is a light touch, but if a buyer that already holds the All Valley cluster is acquiring another Treasure Valley specialty or ER asset, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the friendly-entity structuring and the DEA reissuance as the constraints that actually set the pace.

Deal mechanics specific to Idaho veterinary practice sales

The deal mechanics on an Idaho veterinary sale follow the national pattern with two Idaho-specific bends: ownership runs through a mandatory friendly professional entity plus management company under section 54-2113, and non-competes run on Idaho reasonableness standard, where a covenant of 18 months or less on a key employee is presumed reasonable.

The deal mechanics on an Idaho veterinary sale follow the national pattern with a couple of Idaho-specific bends. Rollover equity typically runs 20 to 30% of proceeds into a Newco or platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Idaho-specific point is ownership itself. Because section 54-2113 restricts a practice to a vet proprietorship, partnership, or professional entity, the transaction is structured as a sale of the operating and real-estate assets into a sponsor management company plus a friendly professional entity owned by an Idaho-licensed veterinarian, not as a clean stock sale of the practice to the fund. The second Idaho-specific point is non-competes. Idaho briefly adopted an employer-friendly statute in 2016 and then repealed it in 2018, landing back on a reasonableness standard under which a covenant with a key employee is enforceable if reasonable in duration, with 18 months or less presumed reasonable, and geography. Sale-of-business non-competes given by a selling owner are the strongest kind and generally hold; associate non-competes on key DVMs are judged on the same reasonableness factors, which gives a buyer a modest retention comfort relative to states that void employee covenants outright. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving veterinary real estate as independent optionality at roughly 5.5% to 7.5% cap rates, and in Idaho the section 63-3022H deduction on qualifying long-term Idaho property can shelter part of the gain on that real-estate leg.

The DVM succession crisis, why Idaho owners are selling now

The engine behind the Idaho selling wave is succession, not a doctor shortage, but Idaho feels the succession question harder than most states because it cannot grow its own replacement doctors. The pipeline is a capped, out-of-state regional program, so an owner who wants to step back has to find a successor from a shallow pool.

The engine behind the Idaho selling wave is succession, not a doctor shortage. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board. Those are exactly the categories Idaho is heavy in. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Idaho feels this acutely because it has no in-state vet school and its WIMU pipeline at Washington State admits only about 11 Idaho residents a year, so a retiring owner in a rural county cannot count on a local successor the way an owner near a large veterinary college can. That pushes more Idaho owners toward a platform or regional-group sale as the realistic exit. With private-equity capital restarted by the late-2025 rate cuts and Thrive already demonstrating that the Treasure Valley is investable, 2026 through 2030 is the structural window when the Idaho owner-operators who built their practices in the 1980s and 1990s reach the age where selling, rather than recruiting a successor they may not find, becomes the practical choice.

Why an Idaho veterinary practice sale needs vertical-specific advice

A generalist advisor who treats an Idaho veterinary practice as any other services business will miss the levers that move the price and will misread the Idaho rules, most importantly by missing that Idaho bars direct corporate ownership and that staffing risk dominates valuation here.

A generalist advisor who treats an Idaho veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and more contestable associate covenants are all veterinary-specific diligence items. Two of them are Idaho-specific. The first is that Idaho bars direct corporate ownership under section 54-2113, so the deal must be built as a friendly professional entity plus management company, and an advisor who assumes a simple stock sale will design a transaction the state does not allow. The second is that Idaho geography and thin, out-of-state labor pipeline make staffing depth the dominant valuation variable, so an advisor who does not understand that a Boise practice and an Idaho Falls practice face completely different buyer pools will misprice both. An Idaho seller working with someone who knows the current platform cap tables, which buyer is actually reachable from their location, and how Idaho licenses and enforces, negotiates as an equal rather than being educated by the buyer diligence team at their own expense.

The 18-24 month pre-sale playbook for Idaho veterinary practices

Idaho owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench given the thin labor pool, clean normalized earnings, the friendly-entity structure mapped early, and being honest about which buyer your location can actually reach.

Idaho owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:

• Stand up a wellness plan 18 to 24 months out. Push penetration past 12 to 15% of eligible cases, break recurring revenue out in the financials, and carry it into the quality-of-earnings report; in an Idaho process this one move can add 75 to 150 basis points over the size-tier baseline, and it is most powerful on a growing Treasure Valley client base.
• Build the associate bench early. With Idaho thin, out-of-state WIMU pipeline, getting from one doctor to two or three is harder here than in states with their own vet school, and it is what lifts you from the 5x to 7x floor into the 7x to 9.5x and 9.5x to 11.5x tiers, so start recruiting well ahead of a sale.
• Move associates to ProSal six to twelve months before signing. Pre-empting the platform production-comp reset neutralizes the 5 to 15% EBITDA haircut buyers otherwise apply.
• Map the friendly-entity structure with counsel first. Because section 54-2113 bars direct corporate ownership, line up the friendly professional entity plus management company plan before outreach so the structure does not become a diligence surprise that stalls the deal.
• Normalize owner compensation. Set owner W-2 and production at market and let the excess fall to EBITDA, documented in payroll and K-1 detail before diligence starts.
• Keep licensure and DEA clean. A clean record with the Idaho Board of Veterinary Medicine, current licensure for the veterinarian of record, and an accurate Schedule II inventory are table stakes in Idaho diligence.
• Decide on the real estate. Carving the building into a separate entity and leasing it back on a long triple-net at market rent creates independent optionality at roughly 5.5% to 7.5% cap rates, and the Idaho 63-3022H deduction can shelter part of the gain on qualifying long-term Idaho property.
• Be honest about your geography. If you are in Boise, run a real process that pits Thrive against a national entrant; if you are in the panhandle, look to Spokane buyers; if you are in eastern Idaho, your realistic buyer may be a regional or local DVM, so set expectations accordingly.

For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.

Common mistakes Idaho veterinary practice owners make when selling

The mistakes that cost Idaho sellers money cluster around misreading the ownership rules, ignoring the thin labor pipeline, assuming a national platform can reach them, and chasing outdated buyer lists.

• Assuming a simple stock sale to a fund. Idaho bars direct corporate ownership under section 54-2113, so a deal must be built as a friendly professional entity plus management company; designing around that late adds cost and delay.
• Ignoring the staffing question. With no in-state vet school and only about 11 Idaho WIMU seats a year, a single-DVM practice with no bench is a retention risk buyers price hard, especially outside Boise.
• Assuming a platform will reach you anywhere in Idaho. Thrive is in Boise; the panhandle answers to Spokane and eastern Idaho answers to no one within two hours, so an isolated practice should not expect an auction.
• Anchoring on revenue instead of adjusted EBITDA, doctor-retention structure and wellness-plan penetration, which are what buyers actually pay for.
• Not modeling the production-comp recut. Platforms reset associates to 22 to 24% straight production and recompute EBITDA, a 5 to 15% cut that is routine unless you pre-empt it.
• Working an outdated buyer list. PetVet is KKR (not Onex), Heartland is Gryphon (not American Securities), AmeriVet is AEA and ADIA (not Imperial Capital), United Veterinary Care is Nordic Capital (not Atlantic Street), and Suveto is Levine Leichtman (not LongueVue); outreach to stale cap tables wastes runway.
• Overlooking the doctor-controlled route. MedVet, roughly 95% DVM and employee owned, and Galaxy Vets, built as an ESOP, are genuine options for an Idaho owner who wants liquidity without handing clinical control to a fund.

Sell Your Veterinary Practice: Idaho and beyond

Companion guides for Idaho sellers:

• Sell Your Veterinary Practice / Animal Hospital (national overview)
• Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation
• How to Sell a Veterinary Practice 2026
• Selling a Veterinary Specialty Hospital in 2026
• How to Prepare Your Veterinary Practice for a Sale or Exit (2026)
• How to Buy a Veterinary Practice in 2026 (Buyer’s Playbook)
• The lower middle market buyer mandate report
• Exit multiple: the 2026 operator’s guide

Idaho veterinary practice sale: 2026 outlook and key takeaways

Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, and Idaho is a real but uneven seat in it. Cumulative private-equity investment reached $51.6 billion over 2017 to 2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), and a structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024 to 2025). In Idaho the story concentrates in the Treasure Valley, where Thrive already runs the All Valley 24/7 cluster and Boise fast growth and rising incomes make it the one genuinely investable metro in the state. A Boise hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a clean licensure and DEA record, real-estate optionality, and a friendly-entity structure mapped to Idaho Code section 54-2113 can realistically reach the upper end of its 9.5x to 11.5x tier. The things that most often cost Idaho sellers money are assuming a simple stock sale the state does not allow, underestimating the staffing risk created by the thin WIMU pipeline, expecting a platform to reach an isolated eastern-Idaho market, outreach to stale buyer lists, and accepting the first offer instead of running a real process where the geography supports one.

This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Idaho ownership restrictions under Idaho Code section 54-2113, Idaho Board of Veterinary Medicine licensure rules, DEA registration transfer, Idaho non-compete standards, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Idaho tax provisions including the section 63-3022H capital-gains deduction are all subject to change; confirm current requirements with qualified Idaho veterinary counsel before relying on them in a transaction.

Related sale guides for Idaho sellers

If you operate a different business in Idaho, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Idaho-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.

Other Idaho industry sale guides

• Sell a CPA / accounting firm in Idaho
• Sell a RIA / wealth management firm in Idaho
• Sell an insurance agency in Idaho
• Sell a managed IT / MSP business in Idaho
• Sell a Commercial HVAC business in Idaho
• Sell Your Idaho Business (state hub with all verticals)

Veterinary practice sales in other states

• Texas
• California
• Florida

Idaho veterinary practice sale: frequently asked questions